CVE-2009-0162 EXPLOIT
4.3
MEDIUM · CVSS 2.0 · EPSS 5.4% (pctl 92)
Patch early
A public exploit exists.
Description
Cross-site scripting (XSS) vulnerability in Safari before 3.2.3, and 4 Public Beta, on Apple Mac OS X 10.5 before 10.5.7 and Windows allows remote attackers to inject arbitrary web script or HTML via a crafted feed: URL.
Scoring
| CVSS | 4.3 (MEDIUM, v2.0) |
|---|---|
| Vector | AV:N/AC:M/Au:N/C:N/I:P/A:N |
| EPSS | 5.35% — more likely to be exploited than 92% of all CVEs |
| Weakness | CWE-79 |
| On CISA KEV | no |
| Public exploit | yes |
| Published | 2009-05-13 |
| Last modified | 2026-06-16 |
Affected (5)
| Vendor | Product |
|---|---|
| apple | mac os x |
| apple | mac os x server |
| apple | safari |
| microsoft | windows vista |
| microsoft | windows xp |
Public exploits
| Source | Title | Date |
|---|---|---|
| exploit-db | Apple Safari 3.2.2 - 'feed:' URI Multiple Input Validation Vulnerabilities | 2009-05-12 |
References
- http://lists.apple.com/archives/security-announce/2009/May/msg00000.html
- http://lists.apple.com/archives/security-announce/2009/May/msg00001.html
- http://lists.apple.com/archives/security-announce/2009/May/msg00002.html
- http://secunia.com/advisories/35056
- http://secunia.com/advisories/35074
- http://support.apple.com/kb/HT3549
- http://support.apple.com/kb/HT3550
- http://www.securityfocus.com/bid/34925
- http://www.securitytracker.com/id?1022206
- http://www.us-cert.gov/cas/techalerts/TA09-133A.html
- http://www.vupen.com/english/advisories/2009/1297
- http://www.vupen.com/english/advisories/2009/1298
- https://exchange.xforce.ibmcloud.com/vulnerabilities/50476
- http://lists.apple.com/archives/security-announce/2009/May/msg00000.html
- http://lists.apple.com/archives/security-announce/2009/May/msg00001.html
- http://lists.apple.com/archives/security-announce/2009/May/msg00002.html
- http://secunia.com/advisories/35056
- http://secunia.com/advisories/35074
- http://support.apple.com/kb/HT3549
- http://support.apple.com/kb/HT3550
→ the Explorer · watch your stack · NVD